Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:507-510

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Amico, M.
Right arrow Articles by Rossi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Amico, M.
Right arrow Articles by Rossi, F.

(Hypertension. 1995;25:507-510.)
© 1995 American Heart Association, Inc.


Articles

Endothelin-1 in Rat Periaqueductal Gray Area Induces Hypertension Via Glutamatergic Receptors

Michele D'Amico; Liberato Berrino; Sabatino Maione; Amelia Filippelli; Anna Pizzirusso; Saverio Vitagliano; Francesco Rossi

From the Institute of Pharmacology and Toxicology, Faculty of Medicine and Surgery, II University of Naples (Italy).

Correspondence to Dr Liberato Berrino, Institute of Pharmacology and Toxicology, Faculty of Medicine and Surgery, II University of Naples, Via Costantinopoli 16, 80138 Naples, Italy.

Abstract We investigated the possible relationship between endothelin-1 injection into the dorsolateral periaqueductal gray area and the glutamatergic system in the control of cardiovascular function. Endothelin-1 was injected into the dorsolateral periaqueductal gray area of freely moving rats at doses ranging from 0.1 to 10 pmol. Endothelin-1 increased arterial blood pressure (from 7.0±1.6 to 55.0±4.1 mm Hg, mean±SEM) in a dose-dependent manner and induced characteristic behavioral changes such as longitudinal rolling of the body (barrel-rolling). DL-2-Amino-5-phosphonovaleric acid and (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[D-{alpha}]cyclohepten-5,10-imine hydrogen maleate, both selective N-methyl-D-aspartate excitatory amino acid receptor antagonists, but not 6-cyano-7-nitroquinoxaline-2,3-dione, a non–N-methyl-D-aspartate excitatory amino acid receptor antagonist, significantly decreased endothelin-1–induced cardiovascular and behavioral changes (P<.01). Prazosin and propranolol, adrenergic blocking agents, and reserpine, a depletor of catecholamine stores, also prevented these effects. We propose that the glutamatergic system may exert, via N-methyl-D-aspartate receptors, a significant influence on endothelin-1–induced cardiovascular and behavioral effects after its injection into the periaqueductal area.


Key Words: receptors, N-methyl-D-aspartate • rats • endothelins • periaqueductal gray • hypertension, experimental




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
Y. Liu, E.-S. Ji, S. Xiang, R. Tamisier, J. Tong, J. Huang, and J. W. Weiss
Exposure to cyclic intermittent hypoxia increases expression of functional NMDA receptors in the rat carotid body
J Appl Physiol, January 1, 2009; 106(1): 259 - 267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Shihara, Y. Hirooka, N. Hori, I. Matsuo, T. Tagawa, S. Suzuki, N. Akaike, and A. Takeshita
Endothelin-1 increases the neuronal activity and augments the responses to glutamate in the NTS
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R658 - R665.
[Abstract] [Full Text] [PDF]